Sharma East India Hosp and Medical Research
Healthcare Services
524548 BSE
₹87.05
Close ·
- P/E
- 24.18
Close 4 Nov 2026 ₹87.05 −53.80 −38.2% 1Y
Start ₹140.85
Key Fundamentals
MicrocapHealthcare ServicesHealthcarePrice-based figures at the close · TTM
- ROCE
- 11.60%
- Debt to Equity
- 0.53
- EPS (TTM)
- ₹3.60
- Book Value
- ₹39.15
- Market Cap
- —
- P/E (TTM)
- 24.18
- P/B
- 2.22
- ROE
- 9.47%
- Dividend Yield
- 0.00%
- EBITDA
- ₹3.80 Cr
- 52W High
- ₹150.50
- 52W Low
- ₹78.00
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
39 Weak
Data confidence 100/100
Category scores
- Quality
- 24
- Poor
- Returns, margins, earnings quality 22% weight
- Valuation
- 41
- Weak
- Cheap vs sector & own history 24% weight
- Growth
- 57
- Good
- Sales & profit trajectory 9% weight
- Financial Health
- 30
- Poor
- Solvency, leverage, coverage 9% weight
- Momentum
- 31
- Poor
- Trend strength, vol-adjusted 12% weight
- Ownership
- 50
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
No strengths listed
Weaknesses
2- Company has a low return on equity of -5.75% over last 3 years.
- Debtor days have increased from 82.3 to 116 days.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Bearish | 7 | 6 | 6 |
| Oscillators | Bullish | 1 | 6 | 2 |
| Moving Averages | Strong Bearish | 6 | 0 | 4 |
Oscillators
Bullish
Bearish
1
Neutral
6
Bullish
2
Overall
Bearish
Bearish
7
Neutral
6
Bullish
6
Moving Averages
Strong Bearish
Bearish
6
Neutral
0
Bullish
4
Key readings
- RSI (14)
- 53.27
- Neutral
- MACD (12,26,9)
- −1.53
- Bullish
- SMA (50)
- 88.49
- Bearish
- SMA (200)
- 99.43
- Bearish
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 10Y | +7.64% |
|---|---|
| 5Y | +34.61% |
| 3Y | +20.12% |
| 1Y | +20.29% |
| TTM | +14.10% |
Net profit
| 10Y | +45.09% |
|---|---|
| 5Y | +14.14% |
| 3Y | +14.32% |
| 1Y | 0.00% |
| TTM | −9.85% |
Operating cash flow
| 10Y | Outflow widened by ₹3.72 Cr |
|---|---|
| 5Y | Turned negative |
| 3Y | Turned negative |
| 1Y | Turned negative |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | +4.99 pp |
|---|---|
| 5Y | +18.22 pp |
| 3Y | −5.82 pp |
| 1Y | −2.15 pp |
| TTM | −1.75 pp |
Revenue by year
| Mar 2017 | ₹17.14 Cr |
|---|---|
| Mar 2018 | ₹16.00 Cr |
| Mar 2019 | ₹14.73 Cr |
| Mar 2020 | ₹16.17 Cr |
| Mar 2021 | ₹8.13 Cr |
| Mar 2022 | ₹17.04 Cr |
| Mar 2023 | ₹20.73 Cr |
| Mar 2024 | ₹18.52 Cr |
| Mar 2025 | ₹29.87 Cr |
| Mar 2026 | ₹35.93 Cr |
Net profit by year
| Mar 2017 | ₹0.08 Cr |
|---|---|
| Mar 2018 | ₹0.13 Cr |
| Mar 2019 | ₹0.27 Cr |
| Mar 2020 | ₹0.31 Cr |
| Mar 2021 | ₹0.64 Cr |
| Mar 2022 | ₹0.68 Cr |
| Mar 2023 | ₹0.83 Cr |
| Mar 2024 | ₹0.66 Cr |
| Mar 2025 | ₹1.24 Cr |
| Mar 2026 | ₹1.24 Cr |
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5.51 | 5.36 | 5.85 | 1.8 | 6.72 | 9.02 | 8.15 | 5.98 | 9.47 | 9.38 | 9.61 | 7.47 | 10.76 |
| Expenses | 4.69 | 4.62 | 4.95 | 6.13 | 5.86 | 7.91 | 7.29 | 5.17 | 8.55 | 8.44 | 8.85 | 6.46 | 9.9 |
| Operating Profit | 0.82 | 0.74 | 0.9 | −4.33 | 0.86 | 1.11 | 0.86 | 0.81 | 0.92 | 0.94 | 0.76 | 1.01 | 0.86 |
| OPM % | 14.88% | 13.81% | 15.38% | −240.56% | 12.8% | 12.31% | 10.55% | 13.55% | 9.71% | 10.02% | 7.91% | 13.52% | 7.99% |
| Other Income | 0 | 0 | 0 | 5.31 | 0 | 0.04 | 0.04 | 0.23 | 0.04 | 0.05 | 0.05 | 0.02 | 0.04 |
| Interest | 0.28 | 0.22 | 0.31 | 0.14 | 0.17 | 0.25 | 0.15 | 0.14 | 0.11 | 0.1 | 0.13 | 0.16 | 0.19 |
| Depreciation | 0.34 | 0.34 | 0.35 | 0.46 | 0.35 | 0.44 | 0.36 | 0.67 | 0.42 | 0.43 | 0.43 | 0.44 | 0.36 |
| PBT | 0.2 | 0.18 | 0.24 | 0.38 | 0.34 | 0.46 | 0.39 | 0.23 | 0.43 | 0.46 | 0.25 | 0.43 | 0.35 |
| Tax % | 55% | −61.11% | 0% | 89.47% | 26.47% | 26.09% | 25.64% | −60.87% | 25.58% | 28.26% | 28% | 0% | 25.71% |
| Net Profit | 0.1 | 0.29 | 0.23 | 0.04 | 0.25 | 0.34 | 0.29 | 0.37 | 0.32 | 0.32 | 0.18 | 0.43 | 0.26 |
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 16.36 | 17.21 | 17.14 | 16 | 14.73 | 16.17 | 8.13 | 17.04 | 20.73 | 18.52 | 29.87 | 35.93 | 37.22 |
| Expenses | 15.11 | 16.33 | 15.51 | 14.54 | 14.09 | 14.24 | 8.79 | 14.79 | 17.43 | 20.4 | 26.21 | 32.3 | 33.65 |
| Operating Profit | 1.25 | 0.88 | 1.63 | 1.46 | 0.64 | 1.93 | −0.66 | 2.25 | 3.3 | −1.88 | 3.66 | 3.63 | 3.57 |
| OPM % | 7.64% | 5.11% | 9.51% | 9.12% | 4.34% | 11.94% | −8.12% | 13.2% | 15.92% | −10.15% | 12.25% | 10.1% | 9.59% |
| Other Income | 0.55 | 0.22 | 0.26 | 0.07 | 1.11 | 0.03 | 2.83 | 0.06 | 0.06 | 5.31 | 0.31 | 0.16 | 0.16 |
| Interest | 0.76 | 0.48 | 1.08 | 0.73 | 0.88 | 1.15 | 0.69 | 0.7 | 1.18 | 0.95 | 0.72 | 0.51 | 0.58 |
| Depreciation | 0.61 | 0.59 | 0.7 | 0.62 | 0.52 | 0.43 | 0.65 | 0.78 | 1.39 | 1.48 | 1.84 | 1.72 | 1.66 |
| PBT | 0.43 | 0.03 | 0.11 | 0.18 | 0.35 | 0.38 | 0.83 | 0.83 | 0.79 | 1 | 1.41 | 1.56 | 1.49 |
| Tax % | −30.23% | 33.33% | 27.27% | 27.78% | 22.86% | 18.42% | 24.1% | 18.07% | −5.06% | 34% | 12.06% | 20.51% | — |
| Net Profit | 0.57 | 0.03 | 0.08 | 0.13 | 0.27 | 0.31 | 0.64 | 0.68 | 0.83 | 0.66 | 1.24 | 1.24 | 1.19 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.16 | 4.16 | 4.16 | 4.16 | 4.16 | 4.16 | 4.16 | 4.16 | 4.16 | 4.16 | 4.16 | 4.16 |
| Reserves | 2.03 | 2.05 | 3.32 | 3.46 | 3.73 | 4.12 | 4.76 | 5.44 | 6.41 | 7.07 | 8.32 | 9.56 |
| Borrowings | 5.97 | 6.47 | 7.51 | 5.38 | 10.89 | 7.42 | 5.98 | 4.35 | 8.3 | 5.04 | 2.26 | 7.29 |
| Other Liabilities | 2.36 | 2.68 | 2.65 | 3.28 | 3.35 | 4.16 | 3.98 | 5.11 | 4.84 | 8.89 | 12.94 | 11.91 |
| Total Liabilities | 14.52 | 15.36 | 17.64 | 16.28 | 22.13 | 19.86 | 18.88 | 19.06 | 23.71 | 25.16 | 27.68 | 32.92 |
| Fixed Assets | 6.58 | 6.01 | 6.4 | 6.07 | 4.73 | 4.41 | 5.51 | 6.85 | 9.1 | 7.7 | 9.37 | 8.45 |
| CWIP | 0 | 0 | 0 | 0.01 | 0.35 | 1.74 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0.31 | 0.31 | 1.79 | 1.79 | 1.8 | 1.89 | 1.89 | 1.89 | 2.05 | 2.05 | 2.05 | 2.05 |
| Other Assets | 7.63 | 9.04 | 9.45 | 8.41 | 15.25 | 11.82 | 11.48 | 10.32 | 12.56 | 15.41 | 16.26 | 22.42 |
| Total Assets | 14.52 | 15.36 | 17.64 | 16.28 | 22.13 | 19.86 | 18.88 | 19.06 | 23.71 | 25.16 | 27.68 | 32.92 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | −0.2 | −0.14 | 0.82 | 3.12 | −1.43 | 1.21 | 1.4 | 2.03 | 1.28 | −1.13 | 6.69 | −3.86 |
| Investing | −0.02 | −0.01 | −0.77 | −0.25 | 1.65 | −1.5 | 2.79 | −2.11 | −3.63 | 5.17 | −3.26 | −0.65 |
| Financing | −0.81 | 0.19 | −0.08 | −2.8 | 4.74 | −4.74 | −2.16 | −1.78 | 2.77 | −4.2 | −3.5 | 4.52 |
| Net Cash Flow | −1.03 | 0.05 | −0.03 | 0.06 | 4.96 | −5.03 | 2.03 | −1.86 | 0.41 | −0.17 | −0.06 | 0.01 |
| Free Cash Flow | −0.7 | −0.68 | 0.05 | 2.86 | 0.22 | −0.29 | 4.19 | −0.09 | −2.36 | 4.01 | 3.35 | −4.66 |
| CFO/OP | −6 | −14 | 53 | 218 | −212 | 66 | −232 | 96 | 39 | 45 | 189 | −95 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 46.63 | 57.69 | 49.4 | 74.14 | 85.49 | 107 | 120 | 72.61 | 75.54 | 50.85 | 79.92 | 116 |
| Inventory Days | 16.83 | 73.23 | — | 98.98 | — | — | 217 | 49.38 | 41.71 | 226 | 211 | 131 |
| Days Payable | 138 | 121 | — | 144 | — | — | 481 | 391 | 305 | 1,659 | 418 | 165 |
| Cash Conversion Cycle | −75.04 | 10.37 | 49.4 | 29.29 | 85.49 | 107 | −144 | −269 | −188 | −1,383 | −127 | 81.96 |
| Working Capital Days | 100 | 27.15 | 20.87 | 18.71 | −75.08 | 46.5 | 48.04 | 35.99 | −2.64 | −116 | 2.69 | 15.64 |
| ROCE % | 8.93% | 4.11% | 8.6% | 6.5% | 1.57% | 8.87% | −8.3% | 10.61% | 12% | −18.61% | 12.77% | 11.58% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Sharma East India Hosp and Medical Research insights
58 extracted metrics across FY09–FY27.
Documents
- General announcements 15 Oct 2026
Frequently Asked Questions about Sharma East India Hosp and Medical Research
What does Sharma East India Hosp and Medical Research Ltd do?
Incorporated in 1989, Sharma East India Hospital and Medical Research Ltd provides medical and healthcare services and real estate services
Where is Sharma East India Hosp and Medical Research Ltd (SHARMEH) listed?
Sharma East India Hosp and Medical Research Ltd trades under code 524548 on the BSE.
Which sector does Sharma East India Hosp and Medical Research Ltd belong to?
Sharma East India Hosp and Medical Research Ltd is classified under the Healthcare Services sector, in the Healthcare Service Provider industry.
What is the PE ratio of Sharma East India Hosp and Medical Research Ltd?
Sharma East India Hosp and Medical Research Ltd trades at a PE ratio of 24.18 as of 4 Nov 2026, on earnings per share of ₹3.6, against a book value of ₹39.15 per share.
What is the 52-week high and low of Sharma East India Hosp and Medical Research Ltd?
Over the last 52 weeks Sharma East India Hosp and Medical Research Ltd has traded between ₹78 and ₹150.5 as of 4 Nov 2026.
What is the Return on Equity (ROE) of Sharma East India Hosp and Medical Research Ltd?
Sharma East India Hosp and Medical Research Ltd reported a return on equity of 9.47%. Its debt-to-equity ratio is 0.53.
Company Information
Incorporated in 1989, Sharma East India Hospital and Medical Research Ltd provides medical and healthcare services and real estate services
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/524548.md for Sharma East India Hosp and Medical Research Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.